Tilray, Inc


Kursmål for aktien: 2.36 $

Det gennemsnitlige kursmål for Tilray, Inc aktien er 2.36 $ hvilket viser forventningen til aktien indenfor de næste 12 mdr. aktien er undervurderet, da kursmålet ligger under det aktuelle aktiekurs. Aktien er undervurderet med 38,82 % Aktien forventes derfor at stige og være en god investering.

Om Tilray, Inc aktien

Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. It offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. The company operates Tilray Medical, a medical platform that provides GMP-certified flowers, oils, vapes, edibles, and topicals. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Tilray, Inc. Tilray Brands Inc. was incorporated in 2018 and is headquartered in New York, New York. Læs mere
$ 1,4B Markedsværdi (Mcap)
$ 743M Omsætning
Drug Manufacturers - Specialty & Generic Industri
USA Handles på børsen
tilray.com Hjemmeside
Sundhed Sektor